Literature DB >> 3771313

Radiotherapy of Kaposi's sarcoma.

C R Hamilton, B J Cummings, A R Harwood.   

Abstract

Between 1958 and 1983, 91 patients with Kaposi's sarcoma were referred to the Princess Margaret Hospital. Eight patients received no specific therapy immediately following their first assessment. Twenty-seven patients were treated by local field radiotherapy, of whom 17 entered complete remission and 6 have remained relapse-free. Fifty-six patients received extended field radiotherapy, usually a single fraction of 8 Gy megavoltage gamma-ray or photon therapy; 38 achieved completed remission, and 24 have remained relapse-free for a median duration of 3 years. The actuarial relapse-free survival for patients treated by local versus extended field radiotherapy significantly favors the extended field technique although the rates of relapse after complete remission has been achieved appear similar. Immunosuppression was present in 12 patients prior to the diagnosis of Kaposi's sarcoma; these patients had a similar response rate to radiation therapy to those who were not known to be immunosuppressed. A rationale for management, and radiation technique and dose are discussed. It is concluded that radiotherapy is an effective treatment for most forms of Kaposi's sarcoma.

Entities:  

Mesh:

Year:  1986        PMID: 3771313     DOI: 10.1016/0360-3016(86)90127-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Radiation-induced changes in lung tissue and development of fibrosis determined by quantitative morphometric methods.

Authors:  R Kraus; F Steinberg; B Rehn; J Bruch; C Streffer
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy.

Authors:  Ferah Yildiz; Mine Genc; Serap Akyurek; Mustafa Cengiz; Enis Ozyar; Ugur Selek; I Lale Atahan
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

3.  137Cesium exposure and spirometry measures in Ukrainian children affected by the Chernobyl nuclear incident.

Authors:  Erik R Svendsen; Igor E Kolpakov; Yevgenia I Stepanova; Vitaliy Y Vdovenko; Maryna V Naboka; Timothy A Mousseau; Lawrence C Mohr; David G Hoel; Wilfried J J Karmaus
Journal:  Environ Health Perspect       Date:  2010-01-25       Impact factor: 9.031

4.  Mucosal Kaposi sarcoma, a Rare Cancer Network study.

Authors:  Juliette Thariat; Youlia Kirova; Terence Sio; Olivier Choussy; Hans Vees; Ulrich Schick; Gilles Poissonnet; Esma Saada; Antoine Thyss; Robert C Miller
Journal:  Rare Tumors       Date:  2012-10-17

5.  Activity testing of alveolar macrophages and changes in surfactant phospholipids after irradiation in bronchoalveolar lavage: experimental and clinical data.

Authors:  F Steinberg; B Rehn; R Kraus; K Quabeck; J Bruch; D W Beelen; U W Schaefer; C Streffer
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

6.  High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma.

Authors:  María Ángeles González Ruiz; Juan Quirós Rivero; Julia Luisa Muñoz García; Joaquín José Cabrera Rodríguez; Yesika Ríos Kavadoy; María Francisca Ropero Carmona; Almudena Corbacho Campos; Fernando García Urra; María Cristina Cruz Muñoz; Amanda Ruiz Herrero; Pedro Almendral Manzano
Journal:  J Contemp Brachytherapy       Date:  2017-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.